The Indian Supreme Court denied a BigPharma patent, further solidfying India's move to become the worlds leader in medicine.
The court rejected the argument that patents are necessary for innovation, and the Hindu of India gets it exactly right when questioning whether it costs so much to develop a drug.
It would naturally strengthen the case for grant of patents and consensus pricing, if the industry opens its books for verification.
Exactly. No independent analysis has ever been made of a medicine development costing. So we have to take BigPharms word for it.
For India to take the #1 spot it needs a free market, and by denying this patent claim India took a step closer.
Feel free to forward this by email to three of your friends.
The court rejected the argument that patents are necessary for innovation, and the Hindu of India gets it exactly right when questioning whether it costs so much to develop a drug.
It would naturally strengthen the case for grant of patents and consensus pricing, if the industry opens its books for verification.
Exactly. No independent analysis has ever been made of a medicine development costing. So we have to take BigPharms word for it.
For India to take the #1 spot it needs a free market, and by denying this patent claim India took a step closer.
Feel free to forward this by email to three of your friends.
0 comments:
Post a Comment